Okogen has a total of 26 patents globally, out of which 7 have been granted. Of these 26 patents, more than 76% patents are active. United States of America is where Okogen has filed the maximum number of patents, followed by Singapore and Japan. Parallelly, United States of America seems
Ohana Biosciences has a total of 12 patents globally, out of which 2 have been granted. Of these 12 patents, more than 33% patents are active. United States of America is where Ohana Biosciences has filed the maximum number of patents, followed by Europe and Israel. Parallelly, United States of
Octant has a total of 26 patents globally, out of which no patents have been granted. Of these 26 patents, more than 80% patents are active. Europe is where Octant has filed the maximum number of patents, followed by Canada and United States of America. Parallelly, United States of America
Pylum Biosciences has a total of 30 patents globally, out of which 20 have been granted. Of these 30 patents, more than 96% patents are active. The United States of America is where Pylum Biosciences has filed the maximum number of patents, followed by Australia and Canada. Parallelly, The United
Rational Vaccines has a total of 6 patents globally. Of these 6 patents, more than 50% patents are active. The United States of America, Canada, and Europe (EPO) are where Rational Vaccines has filed all patents. Parallelly, The United States of America seems to be the main focused R&D center
Rimfrost Technologies has a total of 85 patents globally, out of which 58 have been granted. Of these 85 patents, more than 71% patents are active. The United States of America is where Rimfrost Technologies has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, The
MEP Equine Solutions has a total of 20 patents globally, out of which 15 have been granted. Of these 20 patents, more than 80% patents are active. United States of America is where MEP Equine Solutions has filed the maximum number of patents, followed by New Zealand and Canada. Parallelly,
Meissa Vaccines has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 91% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Meissa Vaccines. Meissa
Marical has a total of 50 patents globally, out of which 30 have been granted. Of these 50 patents, no patents are active. United States of America is where Marical has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of America seems to be
Locanabio has a total of 72 patents globally, out of which 8 have been granted. Of these 72 patents, more than 84% patents are active. United States of America is where Locanabio has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.